“…In our study, we found that mean volume reduction rates (VRRs) for gross tumour volume (GTV) for primary, node and planning target volume (PTV) were 32.44%, 41.48% and 62.95% and mean daily VRRs were 1.05%, 1.38% and 2.01%, respectively. 12 The mean reduction in maximum point dose (D max ) for the spine was 260 cGy (range, 257-658 cGy). Similarly, there was a significant reduction in the volume receiving 10 and 15 Gy for bilateral parotids when ART was applied.…”